J. A. Páramo

Implementation of a management protocol for massive bleeding reduces mortality in non-trauma patients: Results from a single centre audit.

R. Lecumberri, M. Muñoz, A. Alfonso, 2016, Medicina intensiva.

SEA 2022 Standards for Global Control of Cardiovascular Risk.

J. Pedro-Botet, M. Laclaustra, J. Páramo, 2022, Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis.

Matrix Metalloproteinase-10 Effectively Reduces Infarct Size in Experimental Stroke by Enhancing Fibrinolysis via a Thrombin-Activatable Fibrinolysis Inhibitor–Mediated Mechanism

W. Parks, D. Vivien, J. Paramo, 2011, Circulation.

Protective effect of the G-765C COX-2 polymorphism on subclinical atherosclerosis and inflammatory markers in asymptomatic subjects with cardiovascular risk factors.

J. Paramo, C. Roncal, J. Orbe, 2006, Clinica chimica acta; international journal of clinical chemistry.

Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease

J. Paramo, E. Martı́nez-Vila, J. Díez, 2004, Stroke.

Prothrombin fragments in cardiovascular disease.

J. Paramo, José A. Páramo, J. A. Páramo, 2010, Advances in clinical chemistry.

Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors?

J. A. Páramo, Javier Díez, Alberto Benito, 2005, European heart journal.

Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states.

J. Paramo, J. Rifón, Y. López, 1999, Thrombosis research.

Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.

J. Paramo, C. Roncal, J. Orbe, 2004, Cardiovascular research.

Monocyte cyclooxygenase-2 activity: a new therapeutic target for atherosclerosis?

J. Paramo, J. Orbe, J. Rodríguez, 2005, Current drug targets. Cardiovascular & haematological disorders.

Serum levels of matrix metalloproteinase-10 are associated with the severity of atherosclerosis in patients with chronic kidney disease.

J. Orbe, J. Rodríguez, O. Beloqui, 2010, Kidney international.

Ccl20 Is Increased in Hypercholesterolemic Subjects and Is Upregulated by Ldl in Vascular Smooth Muscle Cells Role of Nf-␬b Methods Subjects Characteristics and Assessment of Cardiovascular Risk Human Artery Sampling and Preservation Statistical Analyses Results Circulating Ccl20 Levels in Hyperchol

R. Rodríguez-Calvo, O. Juan-Babot, J. Martínez-González, 2022 .